Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haploidentical bone marrow transplantation for osteopetrosis.

P J Orchard1, J D Dickerman, C H Mathews

  • 1Department of Pediatrics, University of Wisconsin, Madison 53792.

The American Journal of Pediatric Hematology/Oncology
|January 1, 1987
PubMed
Summary

Bone marrow transplantation can treat malignant osteopetrosis by restoring osteoclast function. Even without a perfect HLA match, purging T lymphocytes from donor marrow enables successful treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CSF and plasma neuro-biomarker dynamics after gene therapy for cerebral adrenoleukodystrophy.

Molecular therapy. Advances·2026
Same author

Marrow-ablative chemotherapy followed by tandem autologous hematopoietic cell transplantation in pediatric patients with malignant brain tumors.

Bone marrow transplantation·2017
Same author

Changes in the incidence, patterns and outcomes of graft failure following hematopoietic stem cell transplantation for Hurler syndrome.

Bone marrow transplantation·2017
Same author

Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review of the literature.

Bone marrow transplantation·2017
Same author

Haploidentical transplantation with post-transplant cyclophosphamide following reduced-intensity conditioning for osteopetrosis: outcomes in three children.

Bone marrow transplantation·2016
Same author

Decreased morbidity and mortality of autologous hematopoietic transplants for children with malignant central nervous system tumors: the 'Head Start' trials, 1991-2009.

Bone marrow transplantation·2016

Area of Science:

  • Hematology
  • Immunology
  • Genetics

Background:

  • Malignant osteopetrosis is a rare genetic disorder characterized by defective osteoclast function.
  • Osteoclasts are crucial for bone resorption and remodeling.
  • Current treatments, including HLA-matched bone marrow transplantation, are limited by donor availability.

Observation:

  • Normal osteoclast differentiation and function are essential for bone homeostasis.
  • Pharmacological treatments have shown limited efficacy in patients lacking HLA-matched donors.
  • This study investigates an alternative approach for patients without HLA-matched donors.

Findings:

  • Transplantation of T-lymphocyte-depleted, HLA-nonidentical bone marrow can restore normal osteoclast function.
  • This method bypasses the need for a strict HLA match, expanding treatment options.

Related Experiment Videos

  • Successful restoration of osteoclast function was observed in patients receiving this modified transplant.

    • Implications:

    • This approach offers a viable therapeutic strategy for malignant osteopetrosis patients lacking HLA-matched donors.
    • It may reduce the reliance on HLA-matched donors, potentially increasing transplant accessibility.
    • Further research could explore optimizing T-cell depletion protocols for enhanced outcomes.